| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967779 | Vaccine | 2012 | 7 Pages |
Abstract
⺠Safety concern on the genetic elements of plasmid DNA for clinical usage. ⺠Host genomic modification for the production of safer plasmid DNA. ⺠Alternative selection system to antibiotic resistance marker. ⺠Recent patent and development lead to safe and cost effective plasmid DNA production.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ruzila Ismail, Zeenathul Nazariah Allaudin, Mohd-Azmi Mohd Lila,